Molecular profiling of cell-free DNA and RNA in the blood of patients with non-small cell lung cancer

被引：0

作者：

Reese, Jordan ^{[1
]}

Jackson, Leisa ^{[1
]}

Mellert, Hestia S. ^{[1
]}

Pestano, Gary ^{[1
]}

机构：

[1] Biodesix Inc, Boulder, CO USA

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2019-3980

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3980

引用

页数：1

共 50 条

[31] Profiling Non-Small Cell Lung Cancer: From Tumor to Blood
Tsui, Dana W. Y.
Berger, Michael F.
CLINICAL CANCER RESEARCH, 2016, 22 (04) : 790 - 792
[32] Suppressive Immune Cell Profiling in Patients with Non-Small Cell Lung Cancer
Koh, J.
Lee, K. Y.
Kim, B.
Kim, M. S.
Cho, H. J.
Bae, Y. H.
Ku, B. M.
Sun, J.
Lee, S.
Ahn, J. S.
Park, K.
Ahn, M.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S526 - S526
[33] Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer
Karampini, Elena
Farah, Hassan
Kamal, Nahid
Cane, Paul
Moorhead, Jane
Pomplun, Sabine
King, Juliet
Sethi, Tariq
Spicer, James
McCaughan, Frank
EUROPEAN RESPIRATORY JOURNAL, 2015, 46
[34] Cell-free DNA as a predictive and prognostic marker in adjuvant-treated non-small cell lung cancer
Azkona, E.
Casas, R.
Aurrekoetxea, J.
De Elejoste Echebarria, I.
Fernandez, M.
Sagarduy, J. Azcuna
Garcia, L.
Saiz, M.
Gallastegi, B. Ortega
Calvo, B.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S93 - S93
[35] Optimising primary molecular profiling in non-small cell lung cancer
Schouten, R. D.
Schouten, I.
Schuurbiers, M. M. F.
van der Noort, V.
Damhuis, R. A. M.
van der Heijden, E. H. F. M.
Burgers, J. A.
Barlo, N. P.
van Lindert, A. S. R.
Maas, K. W.
van den Brand, J. J. G.
Smit, A. A. J.
van Haarst, J. M. W.
van der Maat, B.
Schuuring, E.
Blaauwgeers, H.
Willems, S. M.
Monkhorst, K.
van den Broek, D.
van den Heuvel, M. M.
PLOS ONE, 2024, 19 (07):
[36] Clinical utilization of a CLIA-certified cell-free DNA (cfDNA) blood test for identification of targetable molecular alterations in patients with non-small cell lung cancer (NSCLC).
Tran, Hai T.
Elamin, Yasir
Simon, George R.
Blumenschein, George R.
Tsao, Anne S.
Papadimitrakopoulou, Vassiliki
Gibbons, Don Lynn
Fossella, Frank V.
Lanman, Richard Burnham
Banks, Kimberly C.
Byers, Lauren Averett
Zhang, Jianjun
Heymach, John
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[37] Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer
Kapeleris, Joanna
Bark, Juliana MUller
Ranjit, Shanon
Irwin, Darryl
Hartel, Gunter
Warkiani, Majid Ebrahimi
Leo, Paul
O'Leary, Connor
Ladwa, Rahul
O'Byrne, Kenneth
Hughes, Brett G. M.
Punyadeera, Chamindie
HELIYON, 2022, 8 (07)
[38] Utilization of cell-free DNA fragmentomics in minimal residual disease detection for non-small cell lung cancer
Yin, Rong
Wang, Siwei
Li, Ming
Jiang, Feng
Zhang, Jingyuan
Meng, Fanchen
Tang, Wanxiangfu
Bao, Hua
Chen, Hanlin
Wu, Xue
Shao, Yang
Wang, Jie
Zuo, Xianglin
Xu, Lin
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[39] Cell-free DNA as a Biomarker of Residual Disease Following Radiation Therapy for Non-small Cell Lung Cancer
Bratman, S. V.
Eclov, N. C.
Modlin, L. A.
Neal, J.
Loo, B. W.
Wu, G.
Richardson, K.
Newman, A. M.
Alizadeh, A.
Diehn, M.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S713 - S713
[40] The Feasibility of Cell-Free DNA Sequencing for Mutation Detection in Non-Small Cell Lung Cancer Was Determined by Tumor
Ohira, Tatsuo
Sakai, Kazuko
Maehara, Sachio
Juniche, Maeda
Yoshida, Koichi
Hagiwara, Masaru
Kakihana, Masatoshi
Okano, Tetsuya
Kajiwara, Naohiro
Nishio, Kazuto
Ikeda, Norihiko
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S538 - S539

← 1 2 3 4 5 →